Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 1
1948 1
1949 2
1950 1
1956 3
1983 1
1984 3
1985 1
1989 2
1990 2
1991 2
1992 3
1993 8
1994 2
1996 2
1997 3
1998 4
1999 2
2000 3
2001 1
2002 5
2003 2
2004 5
2005 3
2006 4
2007 2
2008 1
2009 7
2010 2
2011 4
2012 5
2013 1
2014 3
2015 3
2016 1
2017 2
2018 6
2019 7
2020 9
2021 6
2022 9
2023 5
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Heier JS, et al. Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085502 Clinical Trial.
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Ophthalmology. 2024 Aug;131(8):914-926. doi: 10.1016/j.ophtha.2024.02.014. Epub 2024 Feb 19. Ophthalmology. 2024. PMID: 38382813 Free article. Clinical Trial.
Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies.
Gauthier J, Bezerra ED, Hirayama AV, Fiorenza S, Sheih A, Chou CK, Kimble EL, Pender BS, Hawkins RM, Vakil A, Phi TD, Steinmetz RN, Jamieson AW, Bar M, Cassaday RD, Chapuis AG, Cowan AJ, Green DJ, Kiem HP, Milano F, Shadman M, Till BG, Riddell SR, Maloney DG, Turtle CJ. Gauthier J, et al. Among authors: steinmetz rn. Blood. 2021 Jan 21;137(3):323-335. doi: 10.1182/blood.2020006770. Blood. 2021. PMID: 32967009 Free PMC article. Clinical Trial.
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells.
Hirayama AV, Gauthier J, Hay KA, Voutsinas JM, Wu Q, Gooley T, Li D, Cherian S, Chen X, Pender BS, Hawkins RM, Vakil A, Steinmetz RN, Acharya UH, Cassaday RD, Chapuis AG, Dhawale TM, Hendrie PC, Kiem HP, Lynch RC, Ramos J, Shadman M, Till BG, Riddell SR, Maloney DG, Turtle CJ. Hirayama AV, et al. Among authors: steinmetz rn. Blood. 2019 Apr 25;133(17):1876-1887. doi: 10.1182/blood-2018-11-887067. Epub 2019 Feb 19. Blood. 2019. PMID: 30782611 Free PMC article. Clinical Trial.
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM; OZURDEX GENEVA Study Group. Haller JA, et al. Ophthalmology. 2010 Jun;117(6):1134-1146.e3. doi: 10.1016/j.ophtha.2010.03.032. Epub 2010 Apr 24. Ophthalmology. 2010. PMID: 20417567 Clinical Trial.
Consistent patterns of common species across tropical tree communities.
Cooper DLM, Lewis SL, Sullivan MJP, Prado PI, Ter Steege H, Barbier N, Slik F, Sonké B, Ewango CEN, Adu-Bredu S, Affum-Baffoe K, de Aguiar DPP, Ahuite Reategui MA, Aiba SI, Albuquerque BW, de Almeida Matos FD, Alonso A, Amani CA, do Amaral DD, do Amaral IL, Andrade A, de Andrade Miranda IP, Angoboy IB, Araujo-Murakami A, Arboleda NC, Arroyo L, Ashton P, Aymard C GA, Baider C, Baker TR, Balinga MPB, Balslev H, Banin LF, Bánki OS, Baraloto C, Barbosa EM, Barbosa FR, Barlow J, Bastin JF, Beeckman H, Begne S, Bengone NN, Berenguer E, Berry N, Bitariho R, Boeckx P, Bogaert J, Bonyoma B, Boundja P, Bourland N, Boyemba Bosela F, Brambach F, Brienen R, Burslem DFRP, Camargo JL, Campelo W, Cano A, Cárdenas S, Cárdenas López D, de Sá Carpanedo R, Carrero Márquez YA, Carvalho FA, Casas LF, Castellanos H, Castilho CV, Cerón C, Chapman CA, Chave J, Chhang P, Chutipong W, Chuyong GB, Cintra BBL, Clark CJ, Coelho de Souza F, Comiskey JA, Coomes DA, Cornejo Valverde F, Correa DF, Costa FRC, Costa JBP, Couteron P, Culmsee H, Cuni-Sanchez A, Dallmeier F, Damasco G, Dauby G, Dávila N, Dávila Doza HP, De Alban JDT, de Assis RL, De Canniere C, De Haulleville T, de Jesus Veiga Carim M, Demarchi LO, Dex… See abstract for full author list ➔ Cooper DLM, et al. Among authors: steinmetz r. Nature. 2024 Jan;625(7996):728-734. doi: 10.1038/s41586-023-06820-z. Epub 2024 Jan 10. Nature. 2024. PMID: 38200314 Free PMC article.
136 results